J&J reduces the production of its unpopular photo on the Covid-19

After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has dramatically reduced its efforts to produce the plans as it faces declining demand.

The New Brunswick, NJ, pharmaceutical company in recent months ended manufacturing deals with companies that helped produce the vaccine during the pandemic, such as Catalent Inc and Sanofi HER.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button